-
1
-
-
0037065502
-
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
-
Antithrombotic Trialists' Collaboration
-
Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
-
(2002)
BMJ
, vol.324
, pp. 71-86
-
-
-
2
-
-
21244446907
-
Low-dose aspirin increases aspirin resistance in patients with coronary artery disease
-
Lee PY, Chen WH, Ng W, et al. Low-dose aspirin increases aspirin resistance in patients with coronary artery disease. Am J Med 2005;118:723-7.
-
(2005)
Am J Med
, vol.118
, pp. 723-727
-
-
Lee, P.Y.1
Chen, W.H.2
Ng, W.3
-
3
-
-
0141762320
-
Pharmacokinetic and pharmacodynamic differences between two low dosages of aspirin may affect therapeutic outcomes
-
Cerletti C, Dell'Elba G, Manarini S, et al. Pharmacokinetic and pharmacodynamic differences between two low dosages of aspirin may affect therapeutic outcomes. Clin Pharmacokinet 2003;42:1059-70.
-
(2003)
Clin Pharmacokinet
, vol.42
, pp. 1059-1070
-
-
Cerletti, C.1
Dell'Elba, G.2
Manarini, S.3
-
4
-
-
10744228434
-
Lack of aspirin effect: Aspirin resistance or resistance to taking aspirin?
-
Cotter G, Shemesh E, Zehavi M, et al. Lack of aspirin effect: aspirin resistance or resistance to taking aspirin? Am Heart J 2004;147:293-300.
-
(2004)
Am Heart J
, vol.147
, pp. 293-300
-
-
Cotter, G.1
Shemesh, E.2
Zehavi, M.3
-
5
-
-
16844362580
-
Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction
-
Schwartz KA, Schwartz DE, Ghosheh K, et al. Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction. Am J Cardiol 2005;95:973-5.
-
(2005)
Am J Cardiol
, vol.95
, pp. 973-975
-
-
Schwartz, K.A.1
Schwartz, D.E.2
Ghosheh, K.3
-
6
-
-
33750924102
-
A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease
-
Biondi-Zoccai GG, Lotrionte M, Agostoni P, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease. Eur Heart J 2006;27:2667-74.
-
(2006)
Eur Heart J
, vol.27
, pp. 2667-2674
-
-
Biondi-Zoccai, G.G.1
Lotrionte, M.2
Agostoni, P.3
-
7
-
-
0029610453
-
Variability in the pharmacokinetics and pharmacodynamics of low dose aspirin in healthy male volunteers
-
Benedek IH, Joshi AS, Pieniaszek HJ, et al. Variability in the pharmacokinetics and pharmacodynamics of low dose aspirin in healthy male volunteers. J Clin Pharmacol 1995;35:1181-6.
-
(1995)
J Clin Pharmacol
, vol.35
, pp. 1181-1186
-
-
Benedek, I.H.1
Joshi, A.S.2
Pieniaszek, H.J.3
-
8
-
-
33747168513
-
Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers
-
Cox D, Maree AO, Dooley M, et al. Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers. Stroke 2006;37:2153-8.
-
(2006)
Stroke
, vol.37
, pp. 2153-2158
-
-
Cox, D.1
Maree, A.O.2
Dooley, M.3
-
9
-
-
33745325634
-
Overcoming aspirin resistance: Increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease
-
Wong S, Morel-Kopp MC, Chen Q, et al. Overcoming aspirin resistance: increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease. Thromb Haemost 2006;95:1042-3.
-
(2006)
Thromb Haemost
, vol.95
, pp. 1042-1043
-
-
Wong, S.1
Morel-Kopp, M.C.2
Chen, Q.3
-
10
-
-
0035807799
-
A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin
-
Ouellet M, Riendeau D, Percival MD. A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin. Proc Natl Acad Sci U S A 2001;98:14583-8.
-
(2001)
Proc Natl Acad Sci U S A
, vol.98
, pp. 14583-14588
-
-
Ouellet, M.1
Riendeau, D.2
Percival, M.D.3
-
11
-
-
37549014900
-
Pyrazolinone analgesics prevent the antiplatelet effect of aspirin and preserve human platelet thromboxane synthesis
-
Hohlfeld T, Zimmermann N, Weber AA, et al. Pyrazolinone analgesics prevent the antiplatelet effect of aspirin and preserve human platelet thromboxane synthesis. J Thromb Haemost 2008;6:166-73.
-
(2008)
J Thromb Haemost
, vol.6
, pp. 166-173
-
-
Hohlfeld, T.1
Zimmermann, N.2
Weber, A.A.3
-
12
-
-
0035924765
-
Cyclooxygenase inhibitors and the antiplatelet effects of aspirin
-
Catella-Lawson F, Reilly MP, Kapoor SC, et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 2001;345:1809-17.
-
(2001)
N Engl J Med
, vol.345
, pp. 1809-1817
-
-
Catella-Lawson, F.1
Reilly, M.P.2
Kapoor, S.C.3
-
13
-
-
17144407991
-
Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects
-
Capone ML, Sciulli MG, Tacconelli S, et al. Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects. J Am Coll Cardiol 2005;45:1295-301.
-
(2005)
J Am Coll Cardiol
, vol.45
, pp. 1295-1301
-
-
Capone, M.L.1
Sciulli, M.G.2
Tacconelli, S.3
-
14
-
-
0037180328
-
Reasons for resistance to aspirin in cardiovascular disease
-
Szczeklik A, Musial J, Undas A. Reasons for resistance to aspirin in cardiovascular disease. Circulation 2002;106:e181-2.
-
(2002)
Circulation
, vol.106
-
-
Szczeklik, A.1
Musial, J.2
Undas, A.3
-
15
-
-
0037431745
-
Platelet responsiveness to aspirin in patients with hyperlipidaemia
-
Friend M, Vucenik I, Miller M. Platelet responsiveness to aspirin in patients with hyperlipidaemia. BMJ 2003;326:82-3.
-
(2003)
BMJ
, vol.326
, pp. 82-83
-
-
Friend, M.1
Vucenik, I.2
Miller, M.3
-
16
-
-
0030754003
-
Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease
-
Davi G, Gresele P, Violi F, et al. Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease. Circulation 1997;96:69-75.
-
(1997)
Circulation
, vol.96
, pp. 69-75
-
-
Davi, G.1
Gresele, P.2
Violi, F.3
-
18
-
-
0028828489
-
Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin
-
Hung J, Lam JY, Lacoste L, et al. Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin. Circulation 1995;92:2432-6.
-
(1995)
Circulation
, vol.92
, pp. 2432-2436
-
-
Hung, J.1
Lam, J.Y.2
Lacoste, L.3
-
19
-
-
0037454168
-
A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease
-
Gum PA, Kottke-Marchant K, Welsh PA, et al. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 2003;41:961-5.
-
(2003)
J Am Coll Cardiol
, vol.41
, pp. 961-965
-
-
Gum, P.A.1
Kottke-Marchant, K.2
Welsh, P.A.3
-
20
-
-
0035894645
-
Epinephrine - via activation of p38-MAPK - abolishes the effect of aspirin on platelet deposition to collagen
-
Mustonen P, van Willigen G, Lassila R. Epinephrine - via activation of p38-MAPK - abolishes the effect of aspirin on platelet deposition to collagen. Thromb Res 2001;104:439-49.
-
(2001)
Thromb Res
, vol.104
, pp. 439-449
-
-
Mustonen, P.1
van Willigen, G.2
Lassila, R.3
-
21
-
-
0028288681
-
Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin
-
Larsson PT, Wallen NH, Hjemdahl P. Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. Circulation 1994;89:1951-7.
-
(1994)
Circulation
, vol.89
, pp. 1951-1957
-
-
Larsson, P.T.1
Wallen, N.H.2
Hjemdahl, P.3
-
22
-
-
0034283498
-
Increased platelet aggregability during exercise in patients with previous myocardial infarction. Lack of inhibition by aspirin
-
Hurlen M, Seljeflot I, Arnesen H. Increased platelet aggregability during exercise in patients with previous myocardial infarction. Lack of inhibition by aspirin. Thromb Res 2000;99:487-94.
-
(2000)
Thromb Res
, vol.99
, pp. 487-494
-
-
Hurlen, M.1
Seljeflot, I.2
Arnesen, H.3
-
23
-
-
34247574729
-
Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin
-
Guthikonda S, Lev EI, Patel R, et al. Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin. J Thromb Haemost 2007;5:490-6.
-
(2007)
J Thromb Haemost
, vol.5
, pp. 490-496
-
-
Guthikonda, S.1
Lev, E.I.2
Patel, R.3
-
25
-
-
0345040152
-
Cyclooxygenase-2 in human platelets as a possible factor in aspirin resistance
-
Weber A-A, Zimmermann K, Meyer-Kirchrath J, et al. Cyclooxygenase-2 in human platelets as a possible factor in aspirin resistance. Lancet 1999;353:900.
-
(1999)
Lancet
, vol.353
, pp. 900
-
-
Weber, A.-A.1
Zimmermann, K.2
Meyer-Kirchrath, J.3
-
26
-
-
0034730075
-
Oxidant stress and aspirin-insensitive thromboxane biosynthesis in severe unstable angina
-
Cipollone F, Ciabattoni G, Patrignani P, et al. Oxidant stress and aspirin-insensitive thromboxane biosynthesis in severe unstable angina. Circulation 2000;102:1007-13.
-
(2000)
Circulation
, vol.102
, pp. 1007-1013
-
-
Cipollone, F.1
Ciabattoni, G.2
Patrignani, P.3
-
27
-
-
18444377050
-
Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets
-
Rocca B, Secchiero P, Ciabattoni G, et al. Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets. Proc Natl Acad Sci U S A 2002;99:7634-9.
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, pp. 7634-7639
-
-
Rocca, B.1
Secchiero, P.2
Ciabattoni, G.3
-
28
-
-
0037101578
-
Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate
-
Macchi L, Christiaens L, Brabant S, et al. Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate. Thromb Res 2002;107:45-9.
-
(2002)
Thromb Res
, vol.107
, pp. 45-49
-
-
Macchi, L.1
Christiaens, L.2
Brabant, S.3
-
29
-
-
0037107263
-
Enhanced platelet aggregation with TRAP-6 and collagen in platelet aggregometry in patients with venous thromboembolism
-
Weber M, Gerdsen F, Gutensohn K, et al. Enhanced platelet aggregation with TRAP-6 and collagen in platelet aggregometry in patients with venous thromboembolism. Thromb Res 2002;107:325-8.
-
(2002)
Thromb Res
, vol.107
, pp. 325-328
-
-
Weber, M.1
Gerdsen, F.2
Gutensohn, K.3
-
30
-
-
0036183757
-
Towards a definition of aspirin resistance: A typological approach
-
Weber A-A, Przytulski B, Schanz A, et al. Towards a definition of aspirin resistance: a typological approach. Platelets 2002;13:37-40.
-
(2002)
Platelets
, vol.13
, pp. 37-40
-
-
Weber, A.-A.1
Przytulski, B.2
Schanz, A.3
-
31
-
-
0035954288
-
Genetic and environmental contributions to platelet aggregation: The Framingham Heart Study
-
O'Donnell CJ, Larson MG, Feng D, et al. Genetic and environmental contributions to platelet aggregation: the Framingham Heart Study. Circulation 2001;103:3051-6.
-
(2001)
Circulation
, vol.103
, pp. 3051-3056
-
-
O'Donnell, C.J.1
Larson, M.G.2
Feng, D.3
-
32
-
-
0037256309
-
Genetic variation in cyclooxygenase 1: Effects on response to aspirin
-
Halushka MK, Walker LP, Halushka PV. Genetic variation in cyclooxygenase 1: effects on response to aspirin. Clin Pharmacol Ther 2003;73:122-30.
-
(2003)
Clin Pharmacol Ther
, vol.73
, pp. 122-130
-
-
Halushka, M.K.1
Walker, L.P.2
Halushka, P.V.3
-
33
-
-
28444484957
-
Cyclooxygenase-1 haplotype modulates platelet response to aspirin
-
Maree AO, Curtin RJ, Chubb A, et al. Cyclooxygenase-1 haplotype modulates platelet response to aspirin. J Thromb Haemost 2005;3:2340-5.
-
(2005)
J Thromb Haemost
, vol.3
, pp. 2340-2345
-
-
Maree, A.O.1
Curtin, R.J.2
Chubb, A.3
-
34
-
-
33646079610
-
High glucose contributes to aspirin insensitivity in streptozotocin-diabetic rats: A multiparametric aggregation study
-
Watala C, Ulicna O, Golanski J, et al. High glucose contributes to aspirin insensitivity in streptozotocin-diabetic rats: a multiparametric aggregation study. Blood Coagul Fibrinolysis 2006;17:113-24.
-
(2006)
Blood Coagul Fibrinolysis
, vol.17
, pp. 113-124
-
-
Watala, C.1
Ulicna, O.2
Golanski, J.3
-
35
-
-
0042735242
-
Resistance in vitro to low-dose aspirin is associated with platelet PlA1 (GP IIIa) polymorphism but not with C807T (GP Ia/IIa) and C-5T Kozak (GP Ibalpha) polymorphisms
-
Macchi L, Christiaens L, Brabant S, et al. Resistance in vitro to low-dose aspirin is associated with platelet PlA1 (GP IIIa) polymorphism but not with C807T (GP Ia/IIa) and C-5T Kozak (GP Ibalpha) polymorphisms. J Am Coll Cardiol 2003;42:1115-9.
-
(2003)
J Am Coll Cardiol
, vol.42
, pp. 1115-1119
-
-
Macchi, L.1
Christiaens, L.2
Brabant, S.3
-
37
-
-
11144232964
-
Dimorphism in the P2Y1 ADP receptor gene is associated with increased platelet activation response to ADP
-
Hetherington SL, Singh RK, Lodwick D, et al. Dimorphism in the P2Y1 ADP receptor gene is associated with increased platelet activation response to ADP. Arterioscler Thromb Vasc Biol 2005;25:252-7.
-
(2005)
Arterioscler Thromb Vasc Biol
, vol.25
, pp. 252-257
-
-
Hetherington, S.L.1
Singh, R.K.2
Lodwick, D.3
-
38
-
-
0346726095
-
Antiplatelet effect of aspirin in patients with cerebrovascular disease
-
Alberts MJ, Bergman DL, Molner E, et al. Antiplatelet effect of aspirin in patients with cerebrovascular disease. Stroke 2004;35:175-8.
-
(2004)
Stroke
, vol.35
, pp. 175-178
-
-
Alberts, M.J.1
Bergman, D.L.2
Molner, E.3
-
39
-
-
0032700388
-
Ex vivo response to aspirin differs in stroke patients with single or recurrent events: A pilot study
-
Chamorro A, Escolar G, Revilla M, et al. Ex vivo response to aspirin differs in stroke patients with single or recurrent events: a pilot study. J Neurol Sci 1999;171:110-4.
-
(1999)
J Neurol Sci
, vol.171
, pp. 110-114
-
-
Chamorro, A.1
Escolar, G.2
Revilla, M.3
-
40
-
-
0037276966
-
Aspirin non-responder status in patients with recurrent cerebral ischemic attacks
-
Grundmann K, Jaschonek K, Kleine B, et al. Aspirin non-responder status in patients with recurrent cerebral ischemic attacks. J Neurol 2003;250:63-6.
-
(2003)
J Neurol
, vol.250
, pp. 63-66
-
-
Grundmann, K.1
Jaschonek, K.2
Kleine, B.3
-
41
-
-
38949119325
-
Aspirin "resistance" and risk of cardiovascular morbidity: Systematic review and meta-analysis
-
Krasopoulos G, Brister SJ, Beattie WS, et al. Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis. BMJ 2008;336:195-8.
-
(2008)
BMJ
, vol.336
, pp. 195-198
-
-
Krasopoulos, G.1
Brister, S.J.2
Beattie, W.S.3
-
42
-
-
34250816849
-
Aspirin resistance and adverse clinical events in patients with coronary artery disease
-
Chen WH, Cheng X, Lee PY, et al. Aspirin resistance and adverse clinical events in patients with coronary artery disease. Am J Med 2007;120:631-5.
-
(2007)
Am J Med
, vol.120
, pp. 631-635
-
-
Chen, W.H.1
Cheng, X.2
Lee, P.Y.3
-
43
-
-
29344466941
-
Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: The role of dual drug resistance
-
Lev EI, Patel RT, Maresh KJ, et al. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance. J Am Coll Cardiol 2006;47:27-33.
-
(2006)
J Am Coll Cardiol
, vol.47
, pp. 27-33
-
-
Lev, E.I.1
Patel, R.T.2
Maresh, K.J.3
-
44
-
-
1542708471
-
Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment
-
Chen WH, Lee PY, Ng W, et al. Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment. J Am Coll Cardiol 2004;43:1122-6.
-
(2004)
J Am Coll Cardiol
, vol.43
, pp. 1122-1126
-
-
Chen, W.H.1
Lee, P.Y.2
Ng, W.3
-
45
-
-
20344408497
-
Stent thrombosis is associated with an impaired response to antiplatelet therapy
-
Wenaweser P, Dorffler-Melly J, Imboden K, et al. Stent thrombosis is associated with an impaired response to antiplatelet therapy. J Am Coll Cardiol 2005;45:1748-52.
-
(2005)
J Am Coll Cardiol
, vol.45
, pp. 1748-1752
-
-
Wenaweser, P.1
Dorffler-Melly, J.2
Imboden, K.3
-
46
-
-
33645982865
-
High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome
-
Cuisset T, Frere C, Quilici J, et al. High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome. J Thromb Haemost 2006;4:542-9.
-
(2006)
J Thromb Haemost
, vol.4
, pp. 542-549
-
-
Cuisset, T.1
Frere, C.2
Quilici, J.3
-
47
-
-
46449107704
-
-
Zimmermann N, Gams E, Winter J, et al. Insufficient inhibition of platelets by aspirin after coronary artery bypass surgery. Circulation 2000;102:II-428.abstract.
-
Zimmermann N, Gams E, Winter J, et al. Insufficient inhibition of platelets by aspirin after coronary artery bypass surgery. Circulation 2000;102:II-428.abstract.
-
-
-
-
48
-
-
9644255792
-
Late saphenous vein graft occlusion in patients with coronary bypass: Possible role of aspirin resistance
-
Yilmaz MB, Balbay Y, Caldir V, et al. Late saphenous vein graft occlusion in patients with coronary bypass: possible role of aspirin resistance. Thromb Res 2005;115:25-9.
-
(2005)
Thromb Res
, vol.115
, pp. 25-29
-
-
Yilmaz, M.B.1
Balbay, Y.2
Caldir, V.3
-
49
-
-
30044450866
-
Endothelial injury and acquired aspirin resistance as promoters of regional thrombin formation and early vein graft failure after coronary artery bypass grafting
-
Poston RS, Gu J, Brown JM, et al. Endothelial injury and acquired aspirin resistance as promoters of regional thrombin formation and early vein graft failure after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2006;131:122-30.
-
(2006)
J Thorac Cardiovasc Surg
, vol.131
, pp. 122-130
-
-
Poston, R.S.1
Gu, J.2
Brown, J.M.3
-
50
-
-
32844467799
-
New modalities and aspects of antiplatelet therapy for stroke prevention
-
Uchiyama S, Nakamura T, Yamazaki M, et al. New modalities and aspects of antiplatelet therapy for stroke prevention. Cerebrovasc Dis 2006;21:Suppl 1:7-16.
-
(2006)
Cerebrovasc Dis
, vol.21
, Issue.SUPPL. 1
, pp. 7-16
-
-
Uchiyama, S.1
Nakamura, T.2
Yamazaki, M.3
-
51
-
-
34347404722
-
Variable platelet response to aspirin in patients with ischemic stroke
-
Hohlfeld T, Weber A-A, Junghans U, et al. Variable platelet response to aspirin in patients with ischemic stroke. Cerebrovasc Dis 2007;24:43-50.
-
(2007)
Cerebrovasc Dis
, vol.24
, pp. 43-50
-
-
Hohlfeld, T.1
Weber, A.-A.2
Junghans, U.3
-
52
-
-
0027279350
-
Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients
-
Grotemeyer KH, Scharafinski HW, Husstedt IW. Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients. Thromb Res 1993;71:397-403.
-
(1993)
Thromb Res
, vol.71
, pp. 397-403
-
-
Grotemeyer, K.H.1
Scharafinski, H.W.2
Husstedt, I.W.3
-
53
-
-
9844224482
-
Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty
-
Mueller MR, Salat A, Stangl P, et al. Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty. Thromb Haemost 1997;78:1003-7.
-
(1997)
Thromb Haemost
, vol.78
, pp. 1003-1007
-
-
Mueller, M.R.1
Salat, A.2
Stangl, P.3
-
54
-
-
0034976798
-
Individual dosing of ASA prophylaxis by controlling platelet aggregation
-
Syrbe G, Redlich H, Ludwig J, et al. Individual dosing of ASA prophylaxis by controlling platelet aggregation. Clin Appl Thromb Haemost 2001;7:209-13.
-
(2001)
Clin Appl Thromb Haemost
, vol.7
, pp. 209-213
-
-
Syrbe, G.1
Redlich, H.2
Ludwig, J.3
-
55
-
-
34547772153
-
Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology
-
Bassand JP, Hamm CW, Ardissino D, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology. Eur Heart J 2007;28:1598-660.
-
(2007)
Eur Heart J
, vol.28
, pp. 1598-1660
-
-
Bassand, J.P.1
Hamm, C.W.2
Ardissino, D.3
-
56
-
-
20144373281
-
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation
-
Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 2005;352:1179-89.
-
(2005)
N Engl J Med
, vol.352
, pp. 1179-1189
-
-
Sabatine, M.S.1
Cannon, C.P.2
Gibson, C.M.3
-
57
-
-
0037145863
-
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial
-
Steinhubl SR, Berger PB, Mann JT III, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;288:2411-20.
-
(2002)
JAMA
, vol.288
, pp. 2411-2420
-
-
Steinhubl, S.R.1
Berger, P.B.2
Mann III, J.T.3
-
58
-
-
29244439006
-
Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: A randomized crossover trial
-
Eikelboom JW, Hankey GJ, Thom J, et al. Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial. J Thromb Haemost 2005;3:2649-55.
-
(2005)
J Thromb Haemost
, vol.3
, pp. 2649-2655
-
-
Eikelboom, J.W.1
Hankey, G.J.2
Thom, J.3
-
59
-
-
33750632582
-
Aspirin resistance or variable response or both?
-
Cheng X, Chen WH, Simon DI. Aspirin resistance or variable response or both? Am J Cardiol 2006;98:Suppl 1:S11-S7.
-
(2006)
Am J Cardiol
, vol.98
, Issue.SUPPL. 1
-
-
Cheng, X.1
Chen, W.H.2
Simon, D.I.3
|